A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00057473
Recruitment Status : Completed
First Posted : April 3, 2003
Last Update Posted : April 14, 2011
Information provided by:
Bristol-Myers Squibb

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2004
  Study Completion Date : February 2004
  Certification/Extension First Submitted : February 3, 2010